Zivo Bioscience Announces Results From Month-Long Coccidiosis Trial In Broiler Chickens; Says All Test Groups Demonstrated Statistically Significant Benefit In Broiler Health Under Simulated Commercial Conditions
Portfolio Pulse from Benzinga Newsdesk
Zivo Bioscience has announced the results of a month-long coccidiosis trial in broiler chickens. The company stated that all test groups demonstrated a statistically significant benefit in broiler health under simulated commercial conditions.
September 19, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zivo Bioscience's successful trial results could potentially boost the company's reputation and stock value in the short term.
Positive trial results often lead to increased investor confidence, which can drive up a company's stock price. Given that the trial demonstrated significant health benefits, this could potentially lead to increased demand for Zivo Bioscience's products, further boosting its stock value.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100